ArticlePhysiological reports2025
Adipocyte-specific Krüppel-like factor 14 overexpression confers sex-biased protection from weight gain on a high-fat diet.
Article in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adipocyte-specific Krüppel-like factor 14 overexpression confers sex-biased protection from weight gain on a high-fat diet.Physiological reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Metabolic syndrome, a constellation of cardiometabolic risk factors including abdominal obesity, predisposes individuals to type 2 diabetes and cardiovascular disease. One frequently replicated MetSyn genetic association signal is located near KLF14 and is linked to central adiposity, with stronger effects observed in females. Lower KLF14 expression has been associated with detrimental metabolic phenotypes; however, the therapeutic effect of KLF14 germline overexpression remains unexplored. Here, we generated an adipocyte-specific Klf14 overexpression mouse model to investigate its role in metabolic regulation. Transgenic overexpression conferred sex-dependent metabolic benefits, including reduced weight gain, improved body composition, and enhanced acute insulin sensitivity, predominantly in female mice. These effects were accompanied by increased expression of genes involved in lipid uptake and thermogenic browning of white adipose tissue. Our findings demonstrate that KLF14 overexpression confers protective metabolic effects in a sex-specific manner and support the potential of KLF14-targeted strategies for treating metabolic syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.